"Response to: “Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?” [Response to Letter]." Pharmacogenomics and Personalized Medicine, , pp. 51–52
This article responds to:
Disclosure
The authors declare no conflict of interest in this communication.